https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22630 Wed 11 Apr 2018 17:05:10 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14698 Wed 11 Apr 2018 16:15:41 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:2759 Wed 11 Apr 2018 12:29:38 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20929 n=41) and female (n=53). Platelet coagulation parameters including factors I, II, V, VII, VIII, IX, X, vWF:Ag and endogenous thrombin potential were measured at baseline and 4 weeks post supplementation with EPA-rich or DHA-rich oil capsules. Results: We have previously reported that platelet aggregation is specifically reduced by supplementation with EPA in males and DHA in females. This sex-specific effect was also observed for decreases in plasma levels of Factor II (-7.9±3.8%, P=.026), Factor V (-6.5±4.5%, P=.022) and vWF:Ag (-7.3±2.1%, P=.034) and was most pronounced in males supplemented with EPA. In contrast, DHA-mediated reduction in platelet aggregation in females was not accompanied by any significant changes in the coagulation parameters tested. Conclusion: Significant interactions between sex and specific LCn-3PUFA exist to reduce procoagulant activity differentially in males vs. females and could have profound effects on managing risk of thrombotic disease.]]> Sat 24 Mar 2018 08:06:03 AEDT ]]>